{"id":"https://openalex.org/W2309708317","doi":"https://doi.org/10.1038/nrclinonc.2016.31","title":"Equal access to innovative therapies and precision cancer care","display_name":"Equal access to innovative therapies and precision cancer care","alternate_titles":[],"publication_year":2016,"publication_date":"2016-03-22","ids":{"openalex":"https://openalex.org/W2309708317","doi":"https://doi.org/10.1038/nrclinonc.2016.31","mag":"2309708317","pmid":"https://pubmed.ncbi.nlm.nih.gov/27000960"},"language":"en","primary_location":{"id":"doi:10.1038/nrclinonc.2016.31","doi":"https://doi.org/10.1038/nrclinonc.2016.31","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrclinonc.2016.31","pdf_url":null,"source":{"id":"https://openalex.org/S41981144","display_name":"Nature Reviews Clinical Oncology","issn_l":"1759-4774","issn":["1759-4774","1759-4782"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2309708317"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007485886","display_name":"Agn\u00e8s Buzyn","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148238","display_name":"Institut National du Cancer","ror":"https://ror.org/03m8vkq32","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210148238"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Agn\u00e8s Buzyn","raw_affiliation_strings":["Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210148238"]},{"raw_affiliation_string":"Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,","institution_ids":["https://openalex.org/I4210148238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042202815","display_name":"Jean\u2010Yves Blay","orcid":"https://orcid.org/0000-0001-7190-120X","observed_orcids":["https://orcid.org/0000-0001-7190-120X"]},"institutions":[{"id":"https://openalex.org/I203339264","display_name":"Universit\u00e9 de Lyon","ror":"https://ror.org/01rk35k63","country_code":"FR","type":"education","lineage":["https://openalex.org/I203339264"]},{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jean-Yves Blay","raw_affiliation_strings":["Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France","University of Lyon, 92 Rue Pasteur, F-69007 Lyon, France","David P\u00e9rol and Jean-Yves Blay are at the Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"University of Lyon, 92 Rue Pasteur, F-69007 Lyon, France","institution_ids":["https://openalex.org/I203339264"]},{"raw_affiliation_string":"David P\u00e9rol and Jean-Yves Blay are at the Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France.,","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009891337","display_name":"Natalie Hoog-Labouret","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148238","display_name":"Institut National du Cancer","ror":"https://ror.org/03m8vkq32","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210148238"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Natalie Hoog-Labouret","raw_affiliation_strings":["Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210148238"]},{"raw_affiliation_string":"Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,","institution_ids":["https://openalex.org/I4210148238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112059971","display_name":"Marta Jimenez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marta Jimenez","raw_affiliation_strings":["R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France","Marta Jimenez and Christian Cailliot are at R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France","institution_ids":["https://openalex.org/I4210141925"]},{"raw_affiliation_string":"Marta Jimenez and Christian Cailliot are at R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France.,","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113698650","display_name":"Fr\u00e9d\u00e9rique Nowak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148238","display_name":"Institut National du Cancer","ror":"https://ror.org/03m8vkq32","country_code":"FR","type":"other","lineage":["https://openalex.org/I4210148238"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Fr\u00e9d\u00e9rique Nowak","raw_affiliation_strings":["Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France","institution_ids":["https://openalex.org/I4210148238"]},{"raw_affiliation_string":"Agn\u00e8s Buzyn, Natalie Hoog-Labouret and Fr\u00e9d\u00e9rique Nowak are at the Institut National du Cancer, 52 avenue Andr\u00e9 Morizet, F-92513 Boulogne-Billancourt, France.,","institution_ids":["https://openalex.org/I4210148238"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041691224","display_name":"Marie\u2010C\u00e9cile Le Deley","orcid":"https://orcid.org/0000-0002-2946-4592","observed_orcids":["https://orcid.org/0000-0002-2946-4592"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405263586","display_name":"Domaine Exp\u00e9rimental de Vassal","ror":"https://ror.org/03a0jtb20","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210088668","https://openalex.org/I4405263586"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Marie-C\u00e9cile Le Deley","raw_affiliation_strings":["Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France","INSERM CSEP Team 2, 114 rue Edouard Vaillant, F-94805, Villejuif, France","Marie-C\u00e9cile Le Deley and Gilles Vassal are at Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2801843802"]},{"raw_affiliation_string":"INSERM CSEP Team 2, 114 rue Edouard Vaillant, F-94805, Villejuif, France","institution_ids":["https://openalex.org/I154526488"]},{"raw_affiliation_string":"Marie-C\u00e9cile Le Deley and Gilles Vassal are at Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France.,","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2801843802","https://openalex.org/I4405263586"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019588141","display_name":"David P\u00e9rol","orcid":"https://orcid.org/0000-0002-6429-7419","observed_orcids":["https://orcid.org/0000-0002-6429-7419"]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"David P\u00e9rol","raw_affiliation_strings":["Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France","David P\u00e9rol and Jean-Yves Blay are at the Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France","institution_ids":["https://openalex.org/I4210105738"]},{"raw_affiliation_string":"David P\u00e9rol and Jean-Yves Blay are at the Centre L\u00e9on B\u00e9rard, 28 Rue Laennec, F-69008, Lyon, France.,","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109913659","display_name":"Christian Cailliot","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210141925","display_name":"UniCancer Group","ror":"https://ror.org/04vhgtv41","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210141925"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Christian Cailliot","raw_affiliation_strings":["R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France","Marta Jimenez and Christian Cailliot are at R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France","institution_ids":["https://openalex.org/I4210141925"]},{"raw_affiliation_string":"Marta Jimenez and Christian Cailliot are at R&D Unicancer, 101 rue de Tolbiac, F-75654 Paris Cedex 13, France.,","institution_ids":["https://openalex.org/I4210141925"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jacques Raynaud","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210148275","display_name":"Fondation ARC pour la Recherche sur le Cancer","ror":"https://ror.org/0489qz649","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210148275"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Jacques Raynaud","raw_affiliation_strings":["ARC Foundation for Cancer Research, 9 Rue Guy Moquet, F-94805 Villejuif, France","Jacques Raynaud is at the ARC Foundation for Cancer Research, 9 Rue Guy Moquet, F-94805 Villejuif, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARC Foundation for Cancer Research, 9 Rue Guy Moquet, F-94805 Villejuif, France","institution_ids":["https://openalex.org/I4210148275"]},{"raw_affiliation_string":"Jacques Raynaud is at the ARC Foundation for Cancer Research, 9 Rue Guy Moquet, F-94805 Villejuif, France.,","institution_ids":["https://openalex.org/I4210148275"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067202962","display_name":"Gilles Vassal","orcid":"https://orcid.org/0000-0003-1780-8869","observed_orcids":["https://orcid.org/0000-0003-1780-8869"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405263586","display_name":"Domaine Exp\u00e9rimental de Vassal","ror":"https://ror.org/03a0jtb20","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210088668","https://openalex.org/I4405263586"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Gilles Vassal","raw_affiliation_strings":["Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France","Marie-C\u00e9cile Le Deley and Gilles Vassal are at Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France.,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Marie-C\u00e9cile Le Deley and Gilles Vassal are at Gustave Roussy, 114 rue Edouard Vaillant, F-94805, Villejuif, France and University Paris-SUD, Facult\u00e9 de M\u00e9decine, 63 Rue Gabriel P\u00e9ri, F-94270 Le Kremlin Bic\u00eatre, France.,","institution_ids":["https://openalex.org/I102197404","https://openalex.org/I2801843802","https://openalex.org/I4405263586"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5007485886"],"corresponding_institution_ids":["https://openalex.org/I4210148238"],"apc_list":null,"apc_paid":null,"fwci":1.2936,"has_fulltext":false,"cited_by_count":51,"citation_normalized_percentile":{"value":0.78242188,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"13","issue":"6","first_page":"385","last_page":"393"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5160999894142151,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.5160999894142151,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.2517000138759613,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.04650000110268593,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/off-label-drug-use","display_name":"off-label drug use","score":0.8379999995231628},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.652999997138977},{"id":"https://openalex.org/keywords/precision-oncology","display_name":"precision oncology","score":0.7319999933242798},{"id":"https://openalex.org/keywords/biomarker-testing","display_name":"biomarker testing","score":0.6029999852180481},{"id":"https://openalex.org/keywords/tumor-molecular-profiling","display_name":"tumor molecular profiling","score":0.8610000014305115},{"id":"https://openalex.org/keywords/advanced-cancer","display_name":"advanced cancer","score":0.6759999990463257},{"id":"https://openalex.org/keywords/access-to-medicines","display_name":"access to medicines","score":0.5070000290870667},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9890000224113464},{"id":"https://openalex.org/keywords/vemurafenib","display_name":"vemurafenib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.46299999952316284}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9059803485870361},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.6951766014099121},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.691622257232666},{"id":"https://openalex.org/C2775832928","wikidata":"https://www.wikidata.org/wiki/Q407954","display_name":"Expanded access","level":2,"score":0.5466093420982361},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4599963128566742},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4433622360229492},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.44175320863723755},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.44008758664131165},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4300435781478882},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.42195838689804077},{"id":"https://openalex.org/C2776131300","wikidata":"https://www.wikidata.org/wiki/Q423111","display_name":"Vemurafenib","level":4,"score":0.4181949496269226},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3490883708000183},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.2325771152973175},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.13867056369781494},{"id":"https://openalex.org/C2994587330","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Metastatic melanoma","level":3,"score":0.0},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000077484","descriptor_name":"Vemurafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077547","descriptor_name":"Crizotinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011720","descriptor_name":"Pyrazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013449","descriptor_name":"Sulfonamides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D056687","descriptor_name":"Off-Label Use","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D057285","descriptor_name":"Precision Medicine","qualifier_ui":"Q000592","qualifier_name":"standards","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/nrclinonc.2016.31","doi":"https://doi.org/10.1038/nrclinonc.2016.31","is_oa":false,"landing_page_url":"https://doi.org/10.1038/nrclinonc.2016.31","pdf_url":null,"source":{"id":"https://openalex.org/S41981144","display_name":"Nature Reviews Clinical Oncology","issn_l":"1759-4774","issn":["1759-4774","1759-4782"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-a","doyens","jufo-2","ki-jl-2","medline","norway-1","poland-200","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature Reviews Clinical Oncology","raw_type":"journal-article"},{"id":"pmid:27000960","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27000960","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Nature reviews. Clinical oncology","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-01792383v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-01792383","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Nature Reviews Clinical Oncology, 2016, &#x27E8;10.1038/nrclinonc.2016.31&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"},{"score":0.5676000118255615,"display_name":"Reduced inequalities","id":"https://metadata.un.org/sdg/10"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320310358","display_name":"Achievement Rewards for College Scientists Foundation","ror":"https://ror.org/054awkm93"},{"id":"https://openalex.org/F4320322361","display_name":"Fondation ARC pour la Recherche sur le Cancer","ror":"https://ror.org/0489qz649"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":47,"referenced_works":["https://openalex.org/W1487371622","https://openalex.org/W1607589687","https://openalex.org/W1846586690","https://openalex.org/W1969567946","https://openalex.org/W1986087325","https://openalex.org/W1989339760","https://openalex.org/W1993428519","https://openalex.org/W1994912526","https://openalex.org/W2000482060","https://openalex.org/W2006047932","https://openalex.org/W2010622913","https://openalex.org/W2011878912","https://openalex.org/W2019573100","https://openalex.org/W2022319775","https://openalex.org/W2028846884","https://openalex.org/W2029409133","https://openalex.org/W2039143190","https://openalex.org/W2045137003","https://openalex.org/W2058657848","https://openalex.org/W2061278019","https://openalex.org/W2068113261","https://openalex.org/W2071068851","https://openalex.org/W2073779538","https://openalex.org/W2091493266","https://openalex.org/W2091985608","https://openalex.org/W2094337993","https://openalex.org/W2098839625","https://openalex.org/W2104340741","https://openalex.org/W2104830962","https://openalex.org/W2107224559","https://openalex.org/W2109397387","https://openalex.org/W2111254482","https://openalex.org/W2117981962","https://openalex.org/W2118167058","https://openalex.org/W2123532766","https://openalex.org/W2127569302","https://openalex.org/W2134701411","https://openalex.org/W2138143000","https://openalex.org/W2145934373","https://openalex.org/W2149592447","https://openalex.org/W2159865757","https://openalex.org/W2163188200","https://openalex.org/W2172208023","https://openalex.org/W2176184837","https://openalex.org/W2302060768","https://openalex.org/W2399908138","https://openalex.org/W2411992442"],"related_works":["https://openalex.org/W1986087325","https://openalex.org/W2010755254","https://openalex.org/W2936803512","https://openalex.org/W3173130354","https://openalex.org/W7055627466","https://openalex.org/W2548893968","https://openalex.org/W2589464884","https://openalex.org/W3116520515","https://openalex.org/W4280564569","https://openalex.org/W2940190235"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2309708317","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
